BioMarin Pharmaceuticals (Nasdaq:BMRN) is trading at unusually high volume Friday with two million shares changing hands. It is currently at two times its average daily volume and trading up $2.63 (+4.9%).
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- BioMarin Pharmaceuticals (Nasdaq: BMRN) is trading at unusually high volume Friday with two million shares changing hands. It is currently at two times its average daily volume and trading up $2.63 (+4.9%) at $55.90 as of 1:50 p.m. ET.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
BioMarin has a market cap of $6.83 billion and is part of the health care sector and drugs industry. Shares are up 12.1% year to date as of the close of trading on Thursday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. TheStreet Ratings rates BioMarin as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. You can view the full BioMarin Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.